Dr. Reddy's and Takeda pact to distribute dengue vaccine
In short
Dr. Reddy's and Takeda Pharma agreed to distribute QDENGA, India's first dengue vaccine. One summary says the two-dose vaccine has CDSCO approval for people aged 4 to 60, and another says it could be available in the first half of 2027.
This matters because it could expand access to a new dengue vaccine in India. The exact rollout timing and distribution details are still not fully stated.
What the reporting says
Dr. Reddy's and Takeda Pharma signed a pact to distribute India's first dengue vaccine, QDENGA, according to the headline and syndicated summaries. The vaccine has been approved by CDSCO for people aged 4 to 60, and one summary says it may be available in the first half of 2027, subject to local regulatory processes. The exact launch timetable and distribution terms are not fully stated.
Why it matters
Dr. Reddy's and Takeda Pharma signed a distribution pact for QDENGA, described in the reporting as India’s first dengue vaccine. The available summaries say CDSCO has approved the two-dose vaccine for people aged 4 to 60, and another notes a possible first-half-2027 availability subject to local regulatory processes. The immediate market relevance is potential vaccine access, but the final launch timing remains uncertain.